{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:38:49Z","timestamp":1771486729893,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.clinbiochem.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T02:01:07Z","timestamp":1486173667000},"page":"678-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Impact of risperidone on leptin and insulin in children and adolescents with autistic spectrum disorders"],"prefix":"10.1016","volume":"50","author":[{"given":"Pornpen","family":"Srisawasdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natchaya","family":"Vanwong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaowaluck","family":"Hongkaew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apichaya","family":"Puangpetch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somlak","family":"Vanavanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boontarika","family":"Intachak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattawat","family":"Ngamsamut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penkhae","family":"Limsila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chonlaphat","family":"Sukasem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin H.","family":"Kroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2017.02.003_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders (4th ed., text revision)","first-page":"70","author":"American Psychiatric Association","year":"2000"},{"issue":"3","key":"10.1016\/j.clinbiochem.2017.02.003_bb0010","first-page":"1","article-title":"Prevalence of autism spectrum disorders\u2014Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.clinbiochem.2017.02.003_bb0015","series-title":"FDA Approves the First Drug to Treat Irritability Associated With Autism, Risperdal","year":"2013"},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.02.003_bb0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/104454604773840472","article-title":"Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications","volume":"14","author":"Gagliano","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"12","key":"10.1016\/j.clinbiochem.2017.02.003_bb0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s11920-013-0426-8","article-title":"Use of antipsychotic medications in pediatric populations: what do the data say?","volume":"15","author":"Penfold","year":"2013","journal-title":"Curr. Psychiatry Rep."},{"issue":"23","key":"10.1016\/j.clinbiochem.2017.02.003_bb0030","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","article-title":"Off-label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends","volume":"21","author":"Carton","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.clinbiochem.2017.02.003_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.eurpsy.2010.09.011","article-title":"Metabolic and endocrine effects of second-generation antipsychotic in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice","volume":"26","author":"De Hert","year":"2011","journal-title":"Eur. Psychiatry"},{"issue":"10","key":"10.1016\/j.clinbiochem.2017.02.003_bb0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/070674371506001005","article-title":"Increased risk of obesity and metabolic dysregulation following 12months of second-generation antipsychotic treatment in children: a prospective cohort study","volume":"60","author":"Ronsley","year":"2015","journal-title":"Can. J. Psychiatr."},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.02.003_bb0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2015.0285","article-title":"Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths","volume":"169","author":"Rubin","year":"2015","journal-title":"JAMA Pediatr."},{"issue":"2","key":"10.1016\/j.clinbiochem.2017.02.003_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hup.1097","article-title":"Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment","volume":"25","author":"Maayan","year":"2010","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.02.003_bb0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.metabol.2014.08.004","article-title":"Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism","volume":"64","author":"Park","year":"2015","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.clinbiochem.2017.02.003_bb0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2183\/pjab.86.131","article-title":"Establishment of a concept of visceral fat syndrome and discovery of adiponectin","volume":"86","author":"Matsuzawa","year":"2010","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.02.003_bb0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4274\/jcrpe.v1i5.233","article-title":"The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome","volume":"1","author":"Alika\u015fifo\u011flu","year":"2009","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2017.02.003_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/er.2012-1053","article-title":"Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals","volume":"34","author":"Moon","year":"2013","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.clinbiochem.2017.02.003_bb0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1192\/bjp.184.1.58","article-title":"Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia","volume":"184","author":"Zhang","year":"2004","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.clinbiochem.2017.02.003_bb0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2017.02.003_bb0085","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamapsychiatry.2013.2053","article-title":"Antipsychotics and the risk of type 2 diabetes mellitus in children and youth","volume":"70","author":"Bobo","year":"2013","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.clinbiochem.2017.02.003_bb0090","unstructured":"Leptin, Mediagnost Gesellschaft f\u00fcr Forschung and Herstellung von Diagnostika, Leptin Sensitive ELISA Assay Kit product No. E077. GmbH, D-72770 Reutlingen, Germany."},{"key":"10.1016\/j.clinbiochem.2017.02.003_bb0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","article-title":"The metabolic syndrome in children and adolescents \u2013 an IDF consensus report","volume":"8","author":"Zimmet","year":"2007","journal-title":"Pediatr. Diabetes"},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.02.003_bb0100","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1373\/49.4.644","article-title":"Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents","volume":"49","author":"Allard","year":"2003","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.clinbiochem.2017.02.003_bb0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5372\/1905-7415.0902.391","article-title":"The age of onset of pubertal development in healthy Thai boys in Khon Kaen, Thailand","volume":"9","author":"Kiatsopit","year":"2015","journal-title":"Asian Biomed."},{"issue":"7","key":"10.1016\/j.clinbiochem.2017.02.003_bb0110","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1176\/appi.ajp.162.7.1361","article-title":"Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6months","volume":"162","author":"Research Units on Pediatric Psychopharmacology Autism Network","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.02.003_bb0115","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/cap.2008.0120","article-title":"Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects","volume":"19","author":"Roke","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2017.02.003_bb0120","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.2337\/db13-0430","article-title":"Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease","volume":"62","author":"Teff","year":"2013","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.02.003_bb0125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/JCP.0000000000000393","article-title":"Metabolic impairments precede changes in hunger and food intake following short-term administration of second-generation antipsychotics","volume":"35","author":"Teff","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.02.003_bb0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jnutbio.2014.12.011","article-title":"Palmitic acid induces central leptin resistance and impairs hepatic glucose and lipid metabolism in male mice","volume":"26","author":"Cheng","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.clinbiochem.2017.02.003_bb0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mce.2015.04.025","article-title":"Arachidonic acid impairs hypothalamic leptin signaling and hepatic energy homeostasis in mice","volume":"412","author":"Cheng","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2017.02.003_bb0140","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.pnpbp.2008.03.015","article-title":"Effects of second generation antipsychotics on leptin and ghrelin","volume":"32","author":"Esen-Danaci","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.clinbiochem.2017.02.003_bb0145","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.tem.2004.07.009","article-title":"Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis","volume":"15","author":"Niswender","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2017.02.003_bb0150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2014.10.070","article-title":"Effects of risperidone treatment on the expression of hypothalamic neuropeptide in appetite regulation in Wistar rats","volume":"1596","author":"Kursungoz","year":"2015","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.02.003_bb0155","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3892\/ijmm.2014.1693","article-title":"SOCS3 and SOCS6 are required for the risperidone-mediated inhibition of insulin and leptin signaling in neuroblastoma cells","volume":"33","author":"Piao","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.02.003_bb0160","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cmet.2006.09.005","article-title":"The pancreatic beta cell is a key site for mediating the effects of leptin on glucose homeostasis","volume":"4","author":"Covey","year":"2006","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.clinbiochem.2017.02.003_bb0165","first-page":"2849","article-title":"Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage","volume":"82","author":"Garcia-Mayor","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.02.003_bb0170","first-page":"1066","article-title":"A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.02.003_bb0175","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2337\/diabetes.51.4.1005","article-title":"The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments","volume":"51","author":"Cnop","year":"2002","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.clinbiochem.2017.02.003_bb0180","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2337\/diabetes.52.6.1475","article-title":"Baltimore longitudinal study of aging the natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore longitudinal study of aging","volume":"52","author":"Meigs","year":"2003","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.clinbiochem.2017.02.003_bb0185","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/070674370905401104","article-title":"Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications","volume":"54","author":"Panagiotopoulos","year":"2009","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.clinbiochem.2017.02.003_bb0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/WNF.0b013e31824d5288","article-title":"Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies","volume":"35","author":"Khalil","year":"2012","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2017.02.003_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054615","article-title":"Association between serum leptin concentrations and insulin resistance: a population-based study from China","volume":"8","author":"Zuo","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clinbiochem.2017.02.003_bb0200","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/01.ftd.0000162868.84596.c3","article-title":"Metabolic ratios of psychotropics as indication of cytochrome P450 2D6\/2C19 genotype","volume":"27","author":"van der Weide","year":"2005","journal-title":"Ther. Drug Monit."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912016305112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912016305112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:51:37Z","timestamp":1757865097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912016305112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0009912016305112"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.02.003","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of risperidone on leptin and insulin in children and adolescents with autistic spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}